Article
Author(s):
The inherent limitations of the standard transrectal ultrasound approach for prostate biopsy have led to both diagnostic and therapeutic dilemmas.
Quiz: CUA guidelines on specimen and timing considerations with genetic testing
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
FDA approves vibegron for OAB symptoms in pharmacologically treated BPH
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
FDA reports Urgent Field Safety Notice on mini PCNL sheath
PSMA-PET shows diagnostic accuracy in initial staging of prostate cancer